Venlafaxine versus Mirtazapine in the Treatment of Undifferentiated Somatoform Disorder: A 12-Week Prospective, Open-Label, Randomized, Parallel-Group Trial

By Han Changsu   Pae Chi-Un   Lee Bun-Hee   Ko Young-Hoon   Masand Prakash S.   Patkar Ashwin A.   Joe Sook-Haeng   Jung In-Kwa  

Clinical Drug Investigation, Vol. 28, Iss. 4, 2008-01 ,pp. : 251-261

Adis International

Access to resources Recommend Favorite

Cardiovascular Safety and Overall Tolerability of Solifenacin in Routine Clinical Use: A 12-Week, Open-Label, Post-Marketing Surveillance Study

By Michel Martin C.  

Drug Safety, Vol. 31, Iss. 6, 2008-01 ,pp. : 505-514

Adis International

Access to resources Recommend Favorite

A randomized, open-label clinical trial of tasisulam sodium versus paclitaxel as second-line treatment in patients with metastatic melanoma

By Hamid Omid   Ilaria Robert   Garbe Claus   Wolter Pascal   Maio Michele   Hutson Thomas E.   Arance Ana   Lorigan Paul   Lee Jeeyun   Hauschild Axel   Mohr Peter   Hahka-Kemppinen Marjo   Kaiser Christopher   Turner P. Kellie   Conti Ilaria   Grob Jean-Jacques  

Cancer, Vol. 120, Iss. 13, 2014-07 ,pp. : 2016-2024

Blackwell Publishing

Access to resources Recommend Favorite

Beneficial acute antidepressant effects of aripiprazole as an adjunctive treatment or monotherapy in bipolar patients unresponsive to mood stabilizers: results from a 16-week open-label trial

By Mazza Marianna   Squillacioti Maria Rosaria   Pecora Riccardo Daniele   Janiri Luigi   Bria Pietro  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3145-3149

Informa Healthcare

Access to resources Recommend Favorite

Clinical and Demographic Predictors of Improvement during Duloxetine Treatment in Patients with Major Depression: An Open-Label Study

By >  

Clinical Drug Investigation, Vol. 31, Iss. 6, 2011-06 ,pp. : 385-405

Adis International

Access to resources Recommend Favorite